Newsletter | June 4, 2025

06.04.25 -- Executing A Product Pivot

SPONSOR

Mark your calendar for BioFuture™ 2025!

BioFuture returns to New York City this October, bringing together pioneers, investors, and decision-makers who are redefining the future of medicine. This year’s summit will focus on the convergence of biopharma, digital medicine, big data, and TechBio. With 600+ attendees, 100+ speakers, and 80+ presenting companies. Learn more and register.

FEATURED PODCAST

Executing A Product Pivot With Vir's Mark Eisner, MD

On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Biotechnology, talks about the company's post-COVID pivot into infectious diseases (Hepatitis Delta and Hepatitis B) and oncology (solid tumors), how he reprioritized the company's development candidates and assimilated Sanofi's acquired T cell engager platform, and his own transition from healthcare provider to clinical research.

INDUSTRY INSIGHTS

Overcoming Complex Patient Recruitment Challenges With Data

Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.

Integrated And Connected Downstream Processing Of mAbs

In this application note, we describe how intensifying two chromatography polishing steps by developing unit operations saves buffer volumes and accelerates the downstream process.

A Day In The Life Of A Clinical Research Site

Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.

The Future Of Oncology Research: Trends And Predictions

In a clinical trial landscape defined by innovation and empathy, the future of oncology research is driven by patient-centric approaches, technological advancements, and collaborative innovations.

Overcoming Challenges To High-Concentration Formulation Development

Explore a systematic, science-driven approach designed to optimize high-concentration formulations through advanced analytical techniques, strategic risk mitigation, and stepwise process development.